Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Company profile
Ticker
ZTS
Exchange
Website
CEO
Kristin Peck
Employees
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Abaxis Asia Limited • Abaxis Europe GmbH • Abaxis South East Europe • Abaxis, Inc. • Alpharma (Bermuda), LLC • Alpharma (Luxembourg) S.A.R.L. • Alpharma Animal Health (Hong Kong) Co. Limited • Alpharma Animal Health Company • Alpharma Euro Holdings, LLC • Alpharma Holdings (Barbados) SRL ...
IRS number
460696167
ZTS stock data
Latest filings (excl ownership)
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Zoetis Announces Third Quarter 2023 Results
2 Nov 23
8-K
Zoetis Declares Fourth Quarter 2023 Dividend
12 Oct 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Zoetis Announces Second Quarter 2023 Results
8 Aug 23
SD
Conflict minerals disclosure
30 May 23
8-K
Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade
25 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
19 May 23
8-K
Zoetis Declares Third Quarter 2023 Dividend
11 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
Transcripts
ZTS
Earnings call transcript
2023 Q3
2 Nov 23
ZTS
Earnings call transcript
2023 Q2
8 Aug 23
ZTS
Earnings call transcript
2023 Q1
4 May 23
ZTS
Earnings call transcript
2022 Q4
14 Feb 23
ZTS
Earnings call transcript
2022 Q3
3 Nov 22
ZTS
Earnings call transcript
2022 Q2
4 Aug 22
ZTS
Earnings call transcript
2022 Q1
5 May 22
ZTS
Earnings call transcript
2021 Q4
15 Feb 22
ZTS
Earnings call transcript
2021 Q3
4 Nov 21
ZTS
Earnings call transcript
2021 Q2
5 Aug 21
Latest ownership filings
4
Roxanne Lagano
30 Nov 23
144
Notice of proposed sale of securities
21 Nov 23
4
KRISTIN C PECK
21 Nov 23
4
Roxanne Lagano
20 Nov 23
144
Notice of proposed sale of securities
17 Nov 23
4
Nicholas Ashton
31 Oct 23
4
Roxanne Lagano
19 Oct 23
144
Notice of proposed sale of securities
18 Oct 23
4
Roxanne Lagano
10 Oct 23
4
KRISTIN C PECK
10 Oct 23
Financial summary
| Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 1.75 bn | 1.75 bn | 1.75 bn | 1.75 bn | 1.75 bn | 1.75 bn |
| Cash burn (monthly) | (no burn) | 62.75 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | n/a | 134.66 mm | n/a | n/a | n/a | n/a |
| Cash remaining | n/a | 1.62 bn | n/a | n/a | n/a | n/a |
| Runway (months of cash) | n/a | 25.8 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
89.8% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 1540 |
| Opened positions | 141 |
| Closed positions | 124 |
| Increased positions | 616 |
| Reduced positions | 556 |
| 13F shares | Current |
|---|---|
| Total value | 71.37 tn |
| Total shares | 412.23 mm |
| Total puts | 1.16 mm |
| Total calls | 1.08 mm |
| Total put/call ratio | 1.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 39.80 mm | $6.92 tn |
| BLK Blackrock | 36.47 mm | $6.34 tn |
| STT State Street | 18.97 mm | $3.30 tn |
| State Farm Mutual Automobile Insurance | 17.13 mm | $2.98 tn |
| Capital International Investors | 15.11 mm | $2.63 tn |
| Alliancebernstein | 14.50 mm | $2.52 tn |
| Wellington Management | 12.34 mm | $2.15 tn |
| MS Morgan Stanley | 12.27 mm | $2.13 tn |
| BAC Bank Of America | 12.25 mm | $2.13 tn |
| T. Rowe Price | 10.47 mm | $1.82 tn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Nov 23 | Lagano Roxanne | Common Stock | Gift | Dispose G | No | No | 0 | 750 | 0.00 | 21,915 |
| 21 Nov 23 | Peck Kristin C | Common Stock | Sell | Dispose S | No | No | 177.0815 | 7,960 | 1.41 mm | 56,843 |
| 21 Nov 23 | Peck Kristin C | Common Stock | Sell | Dispose S | No | No | 176.4459 | 5,040 | 889.29 k | 64,803 |
| 21 Nov 23 | Peck Kristin C | Common Stock | Option exercise | Acquire M | No | Yes | 46.09 | 13,000 | 599.17 k | 69,843 |
| 21 Nov 23 | Peck Kristin C | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0 | 13,000 | 0.00 | 283,014 |
| 17 Nov 23 | Lagano Roxanne | Common Stock | Sell | Dispose S | No | Yes | 177.46 | 923 | 163.80 k | 22,665 |
| 30 Oct 23 | Nicholas Ashton | Common Stock | Payment of exercise | Dispose F | No | No | 157 | 257 | 40.35 k | 235 |
| 30 Oct 23 | Nicholas Ashton | Common Stock | Option exercise | Acquire M | No | No | 0 | 492 | 0.00 | 492 |
| 30 Oct 23 | Nicholas Ashton | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 492.339 | 0.00 | 356.314 |
| 18 Oct 23 | Lagano Roxanne | Common Stock | Sell | Dispose S | No | Yes | 172.92 | 923 | 159.61 k | 23,588 |
News
Press releases
Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference
21 Nov 23
Petco Love Announces Newest Board Members
14 Nov 23
Zoetis Announces Third Quarter 2023 Results
2 Nov 23
Zoetis Declares Fourth Quarter 2023 Dividend
12 Oct 23
Zoetis Named a 100 Best Company for Working Parents by Seramount
10 Oct 23